Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

Jul 28 - Markets closed

World markets

Shanghai 2,994.32 +2.32 (0.08%)
S&P 500 2,167.93 +1.35 (0.06%)
Nikkei 225 16,476.84 -187.98 (-1.13%)
Hang Seng Index 22,174.34 -44.65 (-0.20%)
TSEC 9,076.64 +13.25 (0.15%)
EURO STOXX 50 2,966.10 -33.38 (-1.11%)
CAC 40 4,420.58 -26.38 (-0.59%)
S&P TSX 14,562.92 +16.38 (0.11%)
S&P/ASX 200 5,556.60 +16.90 (0.31%)
BSE Sensex 28,208.62 +184.29 (0.66%)
TA25 1,452.07 -6.51 (-0.45%)
SMI 8,095.07 -126.26 (-1.54%)
ATX 2,228.16 -14.81 (-0.66%)
IBOVESPA 56,557.52 -295.32 (-0.52%)
SET 1,524.58 +9.18 (0.61%)
BIST100 75,244.06 +168.36 (0.22%)
IBEX 8,479.20 -182.20 (-2.10%)
WIG 46,718.98 -84.84 (-0.18%)
TASI 6,335.59 -95.99 (-1.49%)
MERVAL 14,884.34 -62.01 (-0.41%)
IPC 46,573.68 -238.39 (-0.51%)
IDX Composite 5,299.21 +24.85 (0.47%)

Currencies

GBP/USD 1.3148 -0.0082 (-0.62%)
GBP/EUR 1.1876 -0.0079 (-0.66%)
GBP/JPY 138.5557 -0.2310 (-0.17%)
GBP/HKD 10.1985 -0.0634 (-0.62%)
GBP/CNY 8.7552 -0.0702 (-0.80%)
GBP/AUD 1.7543 -0.0053 (-0.30%)
We've signed a blank cheque for nuclear power with Hinkley Point
Every cloud has its silver lining, and for Remainers such as me, one potential upside of Brexit was that it might finally bury that Franco-Chinese folie de grandeur-by-sea, Hinkley Point C. Britain's most ambitious nuclear power station to date ...
'I'm not scared by nuclear': locals divided over Hinkley Point C  
Hinkley Point: Somerset economy poised for boost  
Market Chart
6,721.06 -29.37 (-0.44%)
17,252.33 -13.58 (-0.08%)
3,651.13 -12.82 (-0.35%)
4,292.87 -26.76 (-0.62%)

Top stories

Royal Dutch Shell appealed for investors' patience after announcing a 72 per cent drop in second-quarter earnings as continued weakness in oil and gas prices battered the Anglo-Dutch group.
This document contains certain forward looking statements with respect to the business, strategy and plans of the Bank of Scotland Group and its current goals and expectations relating to its future financial condition and performance.
Rolls-Royce unveiled a forecast-beating set of results that sent shares in the engineer soaring, signalling a turnaround is finally beginning to take hold.
LONDON, July 28 (Reuters) - Generic competition to cholesterol buster Crestor in the U.S. market pushed second-quarter core earnings down by nearly a third at drugmaker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes.
With the sad exception of Greece, the eurozone financial crisis has fallen down the list of problems that European leaders have to confront, with migration and Brexit rising to the top.

Trends

Popular searches on GoogleChange Mkt Cap
SBRY J Sainsbury plc -0.80% 4,319.80M
BOO Boohoo.Com PLC -1.45% 761.01M